Staphylococcus aureus comp. D9 Spray nasale

দেশ: সুইজারল্যান্ড

ভাষা: ইতালীয়

সূত্র: Swissmedic (Swiss Agency for Therapeutic Products)

সক্রিয় উপাদান:

staphylococci aurei subsp. aurei antigenum Spengler ad usum externum D9 (HAB 58a), streptococci pneumoniae antigenum Spengler ad usum externum D9 (HAB 58a), staphylococci aurei subsp. aurei antitoxinum Spengler ad usum externum D9 (HAB 58a), streptococci pneumoniae antitoxinum Spengler ad usum externum D9 (HAB 58a)

থেকে পাওয়া:

steinberg pharma ag

INN (আন্তর্জাতিক নাম):

staphylococci aurei subsp. aurei antigenum Spengler ad usum externum D9 (HAB 58a), streptococci pneumoniae antigenum Spengler ad usum externum D9 (HAB 58a), staphylococci aurei subsp. aurei antitoxinum Spengler ad usum externum D9 (HAB 58a), streptococci pneumoniae antitoxinum Spengler ad usum externum D9 (HAB 58a)

ফার্মাসিউটিকাল ফর্ম:

Spray nasale

রচনা:

Zulassung gilt auch für alle höheren Folgepotenzen. Abgabekategorie B bis D11. Für Folgepotenzen ab D12 gilt die Abgabekategorie D.: staphylococci aurei subsp. aurei antigenum Spengler ad usum externum D9 (HAB 58a) 1.67 g, streptococci pneumoniae antigenum Spengler ad usum externum D9 (HAB 58a) 1.67 g, staphylococci aurei subsp. aurei antitoxinum Spengler ad usum externum D9 (HAB 58a) 3.33 g, streptococci pneumoniae antitoxinum Spengler ad usum externum D9 (HAB 58a) 3.33 g, ad solutionem pro 10 g, corresp. x doses.

শ্রেণী:

B/D

থেরাপিউটিক গ্রুপ:

Farmaci Omeopatici

থেরাপিউটিক এলাকা:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

অনুমোদন অবস্থা:

zugelassen

অনুমোদন তারিখ:

2013-10-31

পণ্য বৈশিষ্ট্য

•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato